Literature DB >> 6535854

Melatonin protects rats from injurious effects of a glucocorticoid, dexamethasone.

W Mori, H Aoyama, N Mori.   

Abstract

Administration of the pineal hormone melatonin (1 mg/day) to growing female rats provided significant protection against the injurious effects (decrease of body weight gain and atrophy of the thymus and adrenals) caused by a glucocorticoid, dexamethasone (0.4-0.01 mg/day). The protective effects were greater at lower doses of dexamethasone, and the adrenal/body weight ratio was well maintained. Histological examination of the thymus and adrenals confirmed both the injurious effect of dexamethasone and the protective effect of melatonin. Dexamethasone also increased glutamic pyruvic transaminase, free fatty acid, triglyceride and glucose in the serum, and melatonin significantly reduced the former two changes. It is proposed that the protection afforded by the pineal hormone melatonin against the injurious effects of dexamethasone is due to a direct anti-glucocorticoid action and dose not involve any other endocrine organ.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6535854

Source DB:  PubMed          Journal:  Jpn J Exp Med        ISSN: 0021-5031


  4 in total

Review 1.  The therapeutic potential of melatonin: a review of the science.

Authors:  Samir Malhotra; Girish Sawhney; Promila Pandhi
Journal:  MedGenMed       Date:  2004-04-13

Review 2.  A review of the multiple actions of melatonin on the immune system.

Authors:  Antonio Carrillo-Vico; Juan M Guerrero; Patricia J Lardone; Russel J Reiter
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

3.  Consequences of treatment with dexamethasone in rats on the susceptibility of total plasma and isolated lipoprotein fractions to copper oxidation.

Authors:  D Belkebir-Mesbah; D Bonnefont-Rousselot; V Frey-Fressart; C Moinard; J Delattre; M P Vasson
Journal:  Endocrine       Date:  1999-06       Impact factor: 3.633

4.  The effect of abolition of the endogenous corticosteroid rhythm on the circadian variation in methotrexate toxicity in the rat.

Authors:  J English; G W Aherne; J Arendt; V Marks
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.